Facial Injectables Market by Product Type (Collagen, Hyaluronic Acid, Botulinum Toxin, Particles and Polymers Fillers (PPF), Calcium hydroxylapatite, Poly-L-lactic acid, Polymethylmethacrylate beads) - Global Opportunity Analysis and Industry Forecast, 2019-2026
|
LI_18473
|
Pages: NA
|
Nov 2019 |
2392 Views
|
|
|
|
Author(s) :
Deepa Tatkare
|
Tables: NA
|
Charts: NA
|
Formats*:
|
|
Facial injectable products, also known as dermal fillers, are products that help in facial rejuvenation. These facial injectable products are mostly used to treat the early signs of ageing such as wrinkles thereby increasing the aesthetic beauty.
Increase in demand to enhance the aesthetic beauty and growth in preference for minimally invasive procedures majorly drive the market. In addition, increase in pool of geriatric population and introduction of better facial injectable such as synthetic calcium hydroxyl apatite fillers boost the market growth. However, strict regulatory concerns of injectable products and side effects of such products such as rashes restrict the market growth.
The report segments the facial injectable market based on type, end-user, and geography. According to the type, it is bifurcated into dermal fillers and anti-ageing injections. Dermal fillers is further categorized into hyaluronic acid fillers, collagen fillers and synthetic fillers while anti-ageing injections are divided into botulinum toxin A and poly-L-lactic acid (PLLA) micro particles By end-user, it is divided into hospitals, dermatology clinics, beauty clinics, and dermatology research institutes. On the basis of application, it is segmented into healthcare, education, banking, financial services & insurance, defense and aerospace, law enforcement, transportation & logistics, and information & technology. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major key players operating in this market include Advanced Dermatology, Merz, Inc., Galderma Laboratories, L.P., ColBar LifeScience Ltd., Allergan, Plc, Valeant Pharmaceuticals North America LLC, Sanofi Biosurgery Inc., and Anika Therapeutics, Inc.
Key Benefits
- This report offers an extensive analysis of the current trends and emerging estimations through 2016‐2023 of the global facial injectable market, which assists to identify the prevailing opportunities.
- Comprehensive analysis of all geographical regions is provided, along with factors that drive and restrict the market growth.
- Quantitative analysis of the market from 2016 to 2023 is provided to showcase the financial scenario of the market.
- The market conditions are comprehensively analyzed region- and country-wise.
Facial Injectable Market Key Segments
By Type
- Dermal Fillers/Injectable Implants
- Hyaluronic Acid
- Collagen Fillers
- Synthetic Fillers
- Anti-aging/ Anti-wrinkle Injections
- Botulinum Toxin A
- Poly-L-Lactic Acid (PLLA) Micro Particles
By End-User
- Hospitals
- Dermatology Clinics
- Beauty Clinics
- Dermatology Research Institutes
By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- UK
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- India
- China
- Japan
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Kingdom of Saudi Arabia
- South Africa
- Rest of LAMEA
Chapter 1 INTRODUCTION
1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
Chapter 2 EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
Chapter 3 MARKET OVERVIEW
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Top Player Positioning/ Market Share Analysis, 2017
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
Chapter 4 FACIAL INJECTABLES MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Dermal Fillers/Injectable Implants
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by type
4.2.2.1. Hyaluronic Acid
4.2.2.1.1. Market size and forecast
4.2.2.2. Collagen Fillers
4.2.2.2.1. Market size and forecast
4.2.2.3. Synthetic Fillers
4.2.2.3.1. Market size and forecast
4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country
4.3. Anti-aging/ Anti-wrinkle Injections
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by type
4.3.2.1. Botulinum Toxin A
4.3.2.1.1. Market size and forecast
4.3.2.2. Poly-L-Lactic Acid (PLLA)
4.3.2.2.1. Market size and forecast
4.3.3. Market size and forecast, by region
4.3.4. Market analysis, by country
Chapter 5 FACIAL INJECTABLES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Aesthetics
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Therapeutics
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
Chapter 6 FACIAL INJECTABLES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Dermatology Clinics
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Beauty Clinics
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
6.5. Dermatology Research Institute
6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country
Chapter 7 FACIAL INJECTABLES MARKET, BY GEOGRAPHY
7.1. Overview
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. North America facial injectables market, by country
7.2.2.1. U.S. facial injectables market
7.2.2.1.1. U.S. market, by product type
7.2.2.1.2. U.S. market, by application
7.2.2.1.3. U.S. market, by end user
7.2.2.2. Canada facial injectables market
7.2.2.2.1. Canada market, by product type
7.2.2.2.2. Canada market, by application
7.2.2.2.3. Canada market, by end user
7.2.2.3. Mexico facial injectables market
7.2.2.3.1. Mexico market, by product type
7.2.2.3.2. Mexico market, by application
7.2.2.3.3. Mexico market, by end user
7.2.3. North America facial injectables market, by product type
7.2.4. North America facial injectables market, by application
7.2.5. North America facial injectables market, by end user
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Europe facial injectables market, by country
7.3.2.1. Germany facial injectables market
7.3.2.1.1. Germany market, by product type
7.3.2.1.2. Germany market, by application
7.3.2.1.3. Germany market, by end user
7.3.2.2. France facial injectables market
7.3.2.2.1. France market, by product type
7.3.2.2.2. France market, by application
7.3.2.2.3. France market, by end user
7.3.2.3. UK facial injectables market
7.3.2.3.1. UK market, by product type
7.3.2.3.2. UK market, by application
7.3.2.3.3. UK market, by end user
7.3.2.4. Italy facial injectables market
7.3.2.4.1. Italy market, by product type
7.3.2.4.2. Italy market, by application
7.3.2.4.3. Italy market, by end user
7.3.2.5. Spain facial injectables market
7.3.2.5.1. Spain market, by product type
7.3.2.5.2. Spain market, by application
7.3.2.5.3. Spain market, by end user
7.3.2.6. Rest of Europe facial injectables market
7.3.2.6.1. Rest of Europe market, by product type
7.3.2.6.2. Rest of Europe market, by application
7.3.2.6.3. Rest of Europe market, by end user
7.3.3. Europe facial injectables market, by product type
7.3.4. Europe facial injectables market, by application
7.3.5. Europe facial injectables market, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Asia-Pacific facial injectables market, by country
7.4.2.1. Japan facial injectables market
7.4.2.1.1. Japan market, by product type
7.4.2.1.2. Japan market, by application
7.4.2.1.3. Japan market, by end user
7.4.2.2. China facial injectables market
7.4.2.2.1. China market, by product type
7.4.2.2.2. China market, by application
7.4.2.2.3. China market, by end user
7.4.2.3. India facial injectables market
7.4.2.3.1. India market, by product type
7.4.2.3.2. India market, by application
7.4.2.3.3. India market, by end user
7.4.2.4. Australia facial injectables market
7.4.2.4.1. Australia market, by product type
7.4.2.4.2. Australia market, by application
7.4.2.4.3. Australia market, by end user
7.4.2.5. Rest of Asia-Pacific facial injectables market
7.4.2.5.1. Rest of Asia-Pacific market, by product type
7.4.2.5.2. Rest of Asia-Pacific market, by application
7.4.2.5.3. Rest of Asia-Pacific market, by end user
7.4.3. Asia-Pacific facial injectables market, by product type
7.4.4. Asia-Pacific facial injectables market, by application
7.4.5. Asia-Pacific facial injectables market, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. LAMEA facial injectables market, by country
7.5.2.1. Brazil facial injectables market
7.5.2.1.1. Brazil market, by product type
7.5.2.1.2. Brazil market, by application
7.5.2.1.3. Brazil market, by end user
7.5.2.2. Saudi Arabia facial injectables market
7.5.2.2.1. Saudi Arabia market, by product type
7.5.2.2.2. Saudi Arabia market, by application
7.5.2.2.3. Saudi Arabia market, by end user
7.5.2.3. South Africa facial injectables market
7.5.2.3.1. South Africa market, by product type
7.5.2.3.2. South Africa market, by application
7.5.2.3.3. South Africa market, by end user
7.5.2.4. Rest of LAMEA facial injectables market
7.5.2.4.1. Rest of LAMEA market, by product type
7.5.2.4.2. Rest of LAMEA market, by application
7.5.2.4.3. Rest of LAMEA market, by end user
7.5.3. LAMEA facial injectables market, by product type
7.5.4. LAMEA facial injectables market, by application
7.5.5. LAMEA facial injectables market, by end user
Chapter 8 COMPANY PROFILES
8.1. Allergan, Plc.
8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments
8.2. Anika Therapeutics, Inc.
8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments
8.3. Bloomage BioTechnology Corporation Limited
8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments
8.4. ColBar LifeScience Ltd.
8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments
8.5. Galderma Laboratories, L.P.
8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments
8.6. Medytox, Inc.
8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments
8.7. Ipsen
8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments
8.8. Merz, Inc.
8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments
8.9. Suneva Medical, Inc.
8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments
8.10. Sinclair Pharma Plc
8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
REQUEST TOC/SAMPLE
Purchase Full Report of
Facial Injectables Market- Global Opportunity Analysis and Industry Forecast, 2019-2026
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in Excel
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5,370$4,833 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited within company/enterprise
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Buy Full Version
"Facial Injectables Market"
Purchase Enquiry